Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced) trials you may qualify forBackground: \- The immune system is made up of special cells, tissues, and organs that fight infections. Problems with this system may lead to frequent, severe…
Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), also known as Autoimmune polyendocrine syndrome type-1 (APS-1), is a disea…
Background: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a problem of the immune system. In people with APECED, the immune system…
The main objective of this study is to generate diagnosis and therapeutic-decision tools through the identification of molecular causes of PIDs with autoimmunit…
Studying genetic predisposition in autoimmune neurological diseases could help improve diagnostic accuracy and offer new treatment possibilities
This randomized crossover study will evaluate the safety, efficacy, and pharmacodynamics of synthetic human PTH 1-34 (PTH) delivered by an insulin pump (omnipod…
The objective of the study will define the mutational spectrum in this French cohort, in patients with APECED syndrome genetically authenticated
This is an open-label, dose-titration trial to study the efficacy, safety, and pharmacokinetics of oral cochleate amphotericin B (CAMB) in the treatment of muco…